| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 1.47e-10 | 5 | 48 | 4 | GO:0004720 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 5.24e-08 | 16 | 48 | 4 | GO:0016641 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 1.38e-07 | 20 | 48 | 4 | GO:0016638 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 8.82e-07 | 31 | 48 | 4 | GO:0004181 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 5.75e-06 | 49 | 48 | 4 | GO:0004180 | |
| GeneOntologyMolecularFunction | transition metal ion binding | CPA6 RTL3 P3H3 LOXL1 LOXL2 CPO LOXL4 CPA3 CPB1 LOXL3 ZSWIM6 RABGGTA | 1.77e-05 | 1189 | 48 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 2.40e-05 | 70 | 48 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | copper ion binding | 3.68e-05 | 78 | 48 | 4 | GO:0005507 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 8.44e-05 | 6 | 48 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.16e-04 | 200 | 48 | 5 | GO:0008237 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 1.18e-04 | 7 | 48 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.41e-04 | 110 | 48 | 4 | GO:0008238 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 2.02e-04 | 9 | 48 | 2 | GO:0015180 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 2.52e-04 | 10 | 48 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 6.65e-04 | 16 | 48 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | prenyltransferase activity | 8.45e-04 | 18 | 48 | 2 | GO:0004659 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 1.64e-03 | 25 | 48 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.20e-03 | 29 | 48 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 4.37e-03 | 41 | 48 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.13e-03 | 891 | 48 | 7 | GO:0008270 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine oxidation | 1.18e-10 | 5 | 47 | 4 | GO:0018057 | |
| GeneOntologyBiologicalProcess | protein oxidation | 2.33e-08 | 14 | 47 | 4 | GO:0018158 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 8.08e-07 | 76 | 47 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 3.30e-05 | 162 | 47 | 5 | GO:0018205 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.04e-04 | 377 | 47 | 6 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.07e-04 | 378 | 47 | 6 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.10e-04 | 379 | 47 | 6 | GO:0045229 | |
| GeneOntologyBiologicalProcess | embryonic process involved in female pregnancy | 2.26e-04 | 10 | 47 | 2 | GO:0060136 | |
| GeneOntologyBiologicalProcess | proline transmembrane transport | 2.76e-04 | 11 | 47 | 2 | GO:0035524 | |
| GeneOntologyBiologicalProcess | L-alanine transport | 2.76e-04 | 11 | 47 | 2 | GO:0015808 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 4.54e-04 | 14 | 47 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | myeloid progenitor cell differentiation | 4.54e-04 | 14 | 47 | 2 | GO:0002318 | |
| GeneOntologyBiologicalProcess | glycine transport | 5.24e-04 | 15 | 47 | 2 | GO:0015816 | |
| GeneOntologyBiologicalProcess | enucleate erythrocyte differentiation | 5.98e-04 | 16 | 47 | 2 | GO:0043353 | |
| GeneOntologyBiologicalProcess | alanine transport | 7.60e-04 | 18 | 47 | 2 | GO:0032328 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.21e-04 | 530 | 49 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 7.93e-04 | 656 | 49 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.07e-04 | 658 | 49 | 7 | GO:0030312 | |
| Domain | Lysyl_oxidase | 2.27e-10 | 5 | 50 | 4 | IPR001695 | |
| Domain | Lysyl_oxidase_CS | 2.27e-10 | 5 | 50 | 4 | IPR019828 | |
| Domain | LYSYL_OXIDASE | 2.27e-10 | 5 | 50 | 4 | PS00926 | |
| Domain | Lysyl_oxidase | 2.27e-10 | 5 | 50 | 4 | PF01186 | |
| Domain | Sp1_fam | 9.43e-09 | 10 | 50 | 4 | IPR030450 | |
| Domain | Zn_pept | 1.35e-07 | 18 | 50 | 4 | SM00631 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.71e-07 | 19 | 50 | 4 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 2.13e-07 | 20 | 50 | 4 | PS00132 | |
| Domain | SRCR | 2.63e-07 | 21 | 50 | 4 | PF00530 | |
| Domain | Peptidase_M14 | 3.88e-07 | 23 | 50 | 4 | PF00246 | |
| Domain | Peptidase_M14 | 3.88e-07 | 23 | 50 | 4 | IPR000834 | |
| Domain | SR | 5.51e-07 | 25 | 50 | 4 | SM00202 | |
| Domain | - | 5.51e-07 | 25 | 50 | 4 | 3.10.250.10 | |
| Domain | SRCR_1 | 6.50e-07 | 26 | 50 | 4 | PS00420 | |
| Domain | SRCR-like_dom | 6.50e-07 | 26 | 50 | 4 | IPR017448 | |
| Domain | SRCR_2 | 6.50e-07 | 26 | 50 | 4 | PS50287 | |
| Domain | SRCR | 7.62e-07 | 27 | 50 | 4 | IPR001190 | |
| Domain | - | 1.00e-06 | 8 | 50 | 3 | 3.30.70.340 | |
| Domain | Propep_M14 | 1.00e-06 | 8 | 50 | 3 | PF02244 | |
| Domain | M14A_act_pep | 1.00e-06 | 8 | 50 | 3 | IPR003146 | |
| Domain | Propept_inh | 1.20e-05 | 17 | 50 | 3 | IPR009020 | |
| Domain | SEA | 6.26e-04 | 14 | 50 | 2 | SM00200 | |
| Domain | Aa_trans | 9.31e-04 | 17 | 50 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 9.31e-04 | 17 | 50 | 2 | IPR013057 | |
| Domain | SEA | 1.71e-03 | 23 | 50 | 2 | PS50024 | |
| Domain | SEA_dom | 1.71e-03 | 23 | 50 | 2 | IPR000082 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 5.13e-03 | 40 | 50 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 5.13e-03 | 40 | 50 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 5.13e-03 | 40 | 50 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 7.93e-03 | 50 | 50 | 2 | PS00650 | |
| Domain | 7tm_2 | 7.93e-03 | 50 | 50 | 2 | PF00002 | |
| Domain | zf-C2H2 | 1.01e-02 | 693 | 50 | 6 | PF00096 | |
| Domain | Laminin_G | 1.06e-02 | 58 | 50 | 2 | IPR001791 | |
| Domain | GPCR_2-like | 1.13e-02 | 60 | 50 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 1.13e-02 | 60 | 50 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.16e-02 | 61 | 50 | 2 | PS50261 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.08e-08 | 76 | 30 | 6 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.00e-08 | 90 | 30 | 6 | M631 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.99e-08 | 18 | 30 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 4.99e-08 | 18 | 30 | 4 | MM14882 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.09e-08 | 50 | 30 | 5 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.68e-07 | 61 | 30 | 5 | M27103 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.30e-06 | 39 | 30 | 4 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.13e-06 | 44 | 30 | 4 | M26969 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.46e-06 | 300 | 30 | 7 | M610 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 5.80e-06 | 17 | 30 | 3 | M39686 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.46e-05 | 258 | 30 | 6 | MM14572 | |
| Pathway | WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE | 4.36e-05 | 5 | 30 | 2 | M45554 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 6.53e-05 | 6 | 30 | 2 | MM1564 | |
| Pathway | BIOCARTA_TERC_PATHWAY | 6.53e-05 | 6 | 30 | 2 | M22047 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 9.13e-05 | 7 | 30 | 2 | MM1541 | |
| Pathway | BIOCARTA_TERT_PATHWAY | 1.22e-04 | 8 | 30 | 2 | M22015 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 4.52e-04 | 15 | 30 | 2 | MM14797 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 5.84e-04 | 17 | 30 | 2 | M27104 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 6.56e-04 | 18 | 30 | 2 | M3430 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 6.56e-04 | 18 | 30 | 2 | MM1385 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.15e-03 | 381 | 30 | 5 | M48063 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 1.96e-03 | 31 | 30 | 2 | MM1343 | |
| Pathway | WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS | 2.09e-03 | 32 | 30 | 2 | M48055 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.22e-03 | 33 | 30 | 2 | M6220 | |
| Pubmed | Structural and functional diversity of lysyl oxidase and the LOX-like proteins. | 4.10e-12 | 4 | 51 | 4 | 12686136 | |
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 21740577 | ||
| Pubmed | 6.14e-11 | 6 | 51 | 4 | 17287949 | ||
| Pubmed | Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. | 2.86e-10 | 8 | 51 | 4 | 19458888 | |
| Pubmed | 8.55e-10 | 10 | 51 | 4 | 23357697 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 19015874 | ||
| Pubmed | 2.97e-09 | 3 | 51 | 3 | 15666829 | ||
| Pubmed | Significance of the Lysyl Oxidase Members Lysyl Oxidase Like 1, 3, and 4 in Gastric Cancer. | 2.97e-09 | 3 | 51 | 3 | 30045039 | |
| Pubmed | Loss of Lysyl Oxidase-like 3 Attenuates Embryonic Lung Development in Mice. | 5.53e-09 | 15 | 51 | 4 | 27645581 | |
| Pubmed | Differential expression of the LOX family genes in human colorectal adenocarcinomas. | 1.19e-08 | 4 | 51 | 3 | 19724858 | |
| Pubmed | Lysyl oxidases: a novel multifunctional amine oxidase family. | 1.19e-08 | 4 | 51 | 3 | 11642359 | |
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 5.07e-08 | 25 | 51 | 4 | 15820306 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 16201967 | ||
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 26954549 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 2.11e-06 | 2 | 51 | 2 | 31299490 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9334251 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19437621 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34565340 | ||
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 2.11e-06 | 2 | 51 | 2 | 8845379 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12958310 | ||
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 2.11e-06 | 2 | 51 | 2 | 2393399 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 14766015 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 11289722 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25538045 | ||
| Pubmed | Transcriptional control of human CD2AP expression: the role of Sp1 and Sp3. | 2.11e-06 | 2 | 51 | 2 | 21604172 | |
| Pubmed | SP1 is a transcriptional regulator of URG-4/URGCP gene in hepatocytes. | 2.11e-06 | 2 | 51 | 2 | 27766531 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21248046 | ||
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 2.11e-06 | 2 | 51 | 2 | 31164147 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30976063 | ||
| Pubmed | Sp1 and Sp3 activate transcription of the human dopamine transporter gene. | 2.11e-06 | 2 | 51 | 2 | 15816870 | |
| Pubmed | Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. | 2.11e-06 | 2 | 51 | 2 | 9628590 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 2.11e-06 | 2 | 51 | 2 | 37735515 | |
| Pubmed | The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. | 2.11e-06 | 2 | 51 | 2 | 14608051 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 26807725 | ||
| Pubmed | An Sp1/Sp3 binding polymorphism confers methylation protection. | 2.11e-06 | 2 | 51 | 2 | 18725933 | |
| Pubmed | Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis. | 2.11e-06 | 2 | 51 | 2 | 29125826 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15951564 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 2.11e-06 | 2 | 51 | 2 | 10973822 | |
| Pubmed | Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. | 2.11e-06 | 2 | 51 | 2 | 9329821 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 2.11e-06 | 2 | 51 | 2 | 10405327 | |
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 2.11e-06 | 2 | 51 | 2 | 22464952 | |
| Pubmed | Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription. | 6.32e-06 | 3 | 51 | 2 | 12801994 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15821099 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 17652716 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12730302 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18417714 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16339759 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12694199 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26162987 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28965583 | ||
| Pubmed | Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. | 6.32e-06 | 3 | 51 | 2 | 14701757 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15118068 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16677608 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15111490 | ||
| Pubmed | Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors. | 6.32e-06 | 3 | 51 | 2 | 17317039 | |
| Pubmed | Sp1 and Sp3 mediate basal and serum-induced expression of human CENP-W. | 6.32e-06 | 3 | 51 | 2 | 20180024 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11850421 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18314536 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12855685 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15297147 | ||
| Pubmed | Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression. | 6.32e-06 | 3 | 51 | 2 | 21554857 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15451065 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18790003 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30561605 | ||
| Pubmed | Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. | 6.32e-06 | 3 | 51 | 2 | 11274368 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12378384 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15466927 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11836249 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12509426 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 36759621 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16052479 | ||
| Pubmed | Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells. | 6.32e-06 | 3 | 51 | 2 | 16529657 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24315822 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 11237613 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 17540780 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16807381 | ||
| Pubmed | Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. | 6.32e-06 | 3 | 51 | 2 | 23028678 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19306294 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15247906 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15482850 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16760259 | ||
| Pubmed | The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms. | 6.32e-06 | 3 | 51 | 2 | 23494965 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23540600 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15777284 | ||
| Pubmed | Involvement of Sp1/Sp3 in the activation of the GATA-1 erythroid promoter in K562 cells. | 6.32e-06 | 3 | 51 | 2 | 18195733 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10816575 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26967243 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 6.32e-06 | 3 | 51 | 2 | 18593936 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21919647 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31863909 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 20091743 | ||
| Pubmed | Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors. | 6.32e-06 | 3 | 51 | 2 | 23523134 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 6.32e-06 | 3 | 51 | 2 | 18163520 | |
| Pubmed | Structural and functional characterization of the mouse tescalcin promoter. | 6.32e-06 | 3 | 51 | 2 | 20540995 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 22682030 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 17906119 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24850855 | ||
| Pubmed | HIV-1 Tat regulates the SOD2 basal promoter by altering Sp1/Sp3 binding activity. | 6.32e-06 | 3 | 51 | 2 | 15706661 | |
| Cytoband | 5q33.1 | 3.87e-04 | 26 | 51 | 2 | 5q33.1 | |
| Cytoband | 3q24 | 5.51e-04 | 31 | 51 | 2 | 3q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 6.46e-04 | 353 | 51 | 4 | chr12p13 | |
| Cytoband | 7q22 | 8.29e-04 | 38 | 51 | 2 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q24 | 1.27e-03 | 47 | 51 | 2 | chr3q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q13 | 3.27e-03 | 76 | 51 | 2 | chr8q13 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.15e-09 | 9 | 33 | 4 | 755 | |
| GeneFamily | Carboxypeptidases | 5.38e-08 | 21 | 33 | 4 | 1321 | |
| GeneFamily | CD molecules|Mucins | 6.64e-04 | 21 | 33 | 2 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.19e-03 | 718 | 33 | 5 | 28 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-08 | 191 | 50 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-08 | 193 | 50 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-08 | 193 | 50 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-08 | 193 | 50 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.98e-06 | 184 | 50 | 5 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 188 | 50 | 5 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 189 | 50 | 5 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 189 | 50 | 5 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 189 | 50 | 5 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 189 | 50 | 5 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 189 | 50 | 5 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-06 | 190 | 50 | 5 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-06 | 190 | 50 | 5 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-06 | 191 | 50 | 5 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-06 | 192 | 50 | 5 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-06 | 192 | 50 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-06 | 192 | 50 | 5 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 192 | 50 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 193 | 50 | 5 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-06 | 193 | 50 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 194 | 50 | 5 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-06 | 194 | 50 | 5 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 194 | 50 | 5 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 194 | 50 | 5 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-06 | 194 | 50 | 5 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 2.63e-06 | 195 | 50 | 5 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 195 | 50 | 5 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 196 | 50 | 5 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 197 | 50 | 5 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 197 | 50 | 5 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.76e-06 | 197 | 50 | 5 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-06 | 198 | 50 | 5 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-06 | 198 | 50 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-06 | 198 | 50 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 198 | 50 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 199 | 50 | 5 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 199 | 50 | 5 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-06 | 200 | 50 | 5 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.97e-06 | 200 | 50 | 5 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-06 | 200 | 50 | 5 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.97e-06 | 200 | 50 | 5 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.97e-06 | 200 | 50 | 5 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.56e-05 | 134 | 50 | 4 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 149 | 50 | 4 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 149 | 50 | 4 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.43e-05 | 150 | 50 | 4 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.62e-05 | 153 | 50 | 4 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-05 | 157 | 50 | 4 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-05 | 157 | 50 | 4 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.52e-05 | 165 | 50 | 4 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.52e-05 | 165 | 50 | 4 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-05 | 169 | 50 | 4 | 319511ea57bbd72c2d95e8516d093689df67a912 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.87e-05 | 169 | 50 | 4 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-05 | 169 | 50 | 4 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-05 | 171 | 50 | 4 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 178 | 50 | 4 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 178 | 50 | 4 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.84e-05 | 179 | 50 | 4 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.94e-05 | 180 | 50 | 4 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 181 | 50 | 4 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 181 | 50 | 4 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 181 | 50 | 4 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.05e-05 | 181 | 50 | 4 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 181 | 50 | 4 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-05 | 182 | 50 | 4 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.16e-05 | 182 | 50 | 4 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 182 | 50 | 4 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.27e-05 | 183 | 50 | 4 | 269afec240a756eec3bbae5f30ec784281af3433 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.38e-05 | 184 | 50 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.50e-05 | 185 | 50 | 4 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-05 | 185 | 50 | 4 | 0e8064bb317f26959d3c59b4f73d0c455161ccd7 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.50e-05 | 185 | 50 | 4 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.61e-05 | 186 | 50 | 4 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.85e-05 | 188 | 50 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.85e-05 | 188 | 50 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 5.97e-05 | 189 | 50 | 4 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | 97772e69e6f51ebffbb5433ca7b40f1048723220 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | 72c2b824acdc43139e6635785df3ed3feb58ec46 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 190 | 50 | 4 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | facs-Aorta-Heart-18m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 191 | 50 | 4 | 6242f83acaf1714e9c1771a832cb67674b19e96d | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.22e-05 | 191 | 50 | 4 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| Drug | amiguanidine | 9.45e-11 | 5 | 49 | 4 | CID000364439 | |
| Drug | 1-benzyl-2-methyl-5-methoxytryptamine | 2.83e-10 | 6 | 49 | 4 | CID000009925 | |
| Drug | BU99006 | 2.83e-10 | 6 | 49 | 4 | CID006603748 | |
| Drug | 5-hydroxyisatin | 2.83e-10 | 6 | 49 | 4 | CID010352011 | |
| Drug | T 794 | 2.83e-10 | 6 | 49 | 4 | CID003077680 | |
| Drug | NSD 2023 | 2.83e-10 | 6 | 49 | 4 | CID000019831 | |
| Drug | 1-PCPA | 2.83e-10 | 6 | 49 | 4 | CID000194548 | |
| Drug | N-cyclopropyl-5,6-dimethoxytryptamine | 2.83e-10 | 6 | 49 | 4 | CID000156277 | |
| Drug | N-cyclopropyl-6,7-dimethoxytryptamine | 2.83e-10 | 6 | 49 | 4 | CID000156278 | |
| Drug | N-cyclopropyl-alpha-methylbenzylamine | 2.83e-10 | 6 | 49 | 4 | CID000362778 | |
| Drug | dimethylphenethylamine | 6.59e-10 | 7 | 49 | 4 | CID000025124 | |
| Drug | BU 224 | 6.59e-10 | 7 | 49 | 4 | CID000002457 | |
| Drug | M 2113 | 6.59e-10 | 7 | 49 | 4 | CID000072895 | |
| Drug | N-(2-aminoethyl)benzamide | 6.59e-10 | 7 | 49 | 4 | CID000423156 | |
| Drug | cimoxatone | 6.59e-10 | 7 | 49 | 4 | CID000052542 | |
| Drug | iproclozide | 6.59e-10 | 7 | 49 | 4 | CID000019063 | |
| Drug | brofaromine | 6.59e-10 | 7 | 49 | 4 | CID000044570 | |
| Drug | tetrahydroharmine | 6.59e-10 | 7 | 49 | 4 | CID000159809 | |
| Drug | 4'-amino-MPTP | 6.59e-10 | 7 | 49 | 4 | CID000086263 | |
| Drug | 4-methoxytranylcypromine | 6.59e-10 | 7 | 49 | 4 | CID003082143 | |
| Drug | 1-Phenylcyclobutylamine | 6.59e-10 | 7 | 49 | 4 | CID000152214 | |
| Drug | JB 835 | 6.59e-10 | 7 | 49 | 4 | CID000152988 | |
| Drug | 1-benzylcyclopropylamine | 6.59e-10 | 7 | 49 | 4 | CID000152923 | |
| Drug | RS-2232 | 6.59e-10 | 7 | 49 | 4 | CID000134882 | |
| Drug | SR 95191 | 6.59e-10 | 7 | 49 | 4 | CID000072119 | |
| Drug | p-dimethylaminomethylbenzylamine | 6.59e-10 | 7 | 49 | 4 | CID000193714 | |
| Drug | MPTP-3-ol | 6.59e-10 | 7 | 49 | 4 | CID000100194 | |
| Drug | AC1O5VTH | 1.32e-09 | 8 | 49 | 4 | CID006441710 | |
| Drug | AC1Q6B1A | 1.32e-09 | 8 | 49 | 4 | CID000088562 | |
| Drug | 4-chlorobenzylamine | 1.32e-09 | 8 | 49 | 4 | CID000066036 | |
| Drug | amezinium | 1.32e-09 | 8 | 49 | 4 | CID000071926 | |
| Drug | mebanazine | 1.32e-09 | 8 | 49 | 4 | CID000006179 | |
| Drug | mofegiline | 1.32e-09 | 8 | 49 | 4 | CID006437850 | |
| Drug | pyrazidol | 1.32e-09 | 8 | 49 | 4 | CID000068802 | |
| Drug | 4-fluorotranylcypromine | 1.32e-09 | 8 | 49 | 4 | CID003082666 | |
| Drug | ranbezolid | 1.32e-09 | 8 | 49 | 4 | CID000496993 | |
| Drug | 2-propyl-pentylamine | 1.32e-09 | 8 | 49 | 4 | CID000170419 | |
| Drug | Q 192 | 1.32e-09 | 8 | 49 | 4 | CID000077317 | |
| Drug | Lilly 51641 | 2.37e-09 | 9 | 49 | 4 | CID000021485 | |
| Drug | 3-amino-2-oxazolidinone | 2.37e-09 | 9 | 49 | 4 | CID000065725 | |
| Drug | toloxatone | 2.37e-09 | 9 | 49 | 4 | CID000034521 | |
| Drug | MDL 72392 | 2.37e-09 | 9 | 49 | 4 | CID006439254 | |
| Drug | AC1L4KA6 | 2.37e-09 | 9 | 49 | 4 | CID000158620 | |
| Drug | AC1L1BMC | 2.37e-09 | 9 | 49 | 4 | CID000001500 | |
| Drug | FLA 336 | 2.37e-09 | 9 | 49 | 4 | CID000123706 | |
| Drug | RS-8359 | 2.37e-09 | 9 | 49 | 4 | CID000164116 | |
| Drug | pinoline | 2.37e-09 | 9 | 49 | 4 | CID000001868 | |
| Drug | Ro 16-6491 | 2.37e-09 | 9 | 49 | 4 | CID000004289 | |
| Drug | FLA 365 | 2.37e-09 | 9 | 49 | 4 | CID000072776 | |
| Drug | J 508 | 2.37e-09 | 9 | 49 | 4 | CID000155219 | |
| Drug | EXP 561 | 3.94e-09 | 10 | 49 | 4 | CID000027696 | |
| Drug | U-0521 | 3.94e-09 | 10 | 49 | 4 | CID000021632 | |
| Drug | acetylcadaverine | 3.94e-09 | 10 | 49 | 4 | CID000189087 | |
| Drug | Monase | 3.94e-09 | 10 | 49 | 4 | CID000008366 | |
| Drug | 3-dimethylamino-1-propyne | 3.94e-09 | 10 | 49 | 4 | CID000081643 | |
| Drug | N-cyclopropylbenzylamine | 3.94e-09 | 10 | 49 | 4 | CID000025866 | |
| Drug | safrazine | 3.94e-09 | 10 | 49 | 4 | CID000034041 | |
| Drug | NmiQ | 3.94e-09 | 10 | 49 | 4 | CID000019850 | |
| Drug | NSC-169892 | 3.94e-09 | 10 | 49 | 4 | CID000043479 | |
| Drug | psychogenic | 6.10e-09 | 31 | 49 | 5 | CID000006089 | |
| Drug | befloxatone | 6.18e-09 | 11 | 49 | 4 | CID000060824 | |
| Drug | 4-hydroxy-3-methoxyphenylglycol-piperazine | 6.18e-09 | 11 | 49 | 4 | CID002723890 | |
| Drug | NSC55260 | 6.18e-09 | 11 | 49 | 4 | CID005356351 | |
| Drug | Amiflamina | 6.18e-09 | 11 | 49 | 4 | CID000071221 | |
| Drug | FNPA | 9.25e-09 | 12 | 49 | 4 | CID000093121 | |
| Drug | anisylamine | 9.25e-09 | 12 | 49 | 4 | CID000075452 | |
| Drug | 2-(2-benzofuranyl)-2-imidazoline | 9.25e-09 | 12 | 49 | 4 | CID003080926 | |
| Drug | AbeAdo | 9.25e-09 | 12 | 49 | 4 | CID006436013 | |
| Drug | kojic amine | 9.25e-09 | 12 | 49 | 4 | CID000003841 | |
| Drug | HLA20 | 9.25e-09 | 12 | 49 | 4 | CID006918819 | |
| Drug | tylciprine | 9.25e-09 | 12 | 49 | 4 | CID000026069 | |
| Drug | pheniprazine | 9.25e-09 | 12 | 49 | 4 | CID000005929 | |
| Drug | viloxazine | 9.25e-09 | 12 | 49 | 4 | CID000005666 | |
| Drug | MPDP | 9.25e-09 | 12 | 49 | 4 | CID000150458 | |
| Drug | SKF 64139 | 1.33e-08 | 13 | 49 | 4 | CID000123919 | |
| Drug | isocarboxazid | 1.86e-08 | 14 | 49 | 4 | CID000003759 | |
| Drug | kynuramine | 1.86e-08 | 14 | 49 | 4 | CID000009692 | |
| Drug | FMMT | 1.86e-08 | 14 | 49 | 4 | CID006438682 | |
| Drug | MDL 72145 | 1.86e-08 | 14 | 49 | 4 | CID006438383 | |
| Drug | benzylhydrazine | 1.86e-08 | 14 | 49 | 4 | CID000011157 | |
| Drug | lazabemide | 1.86e-08 | 14 | 49 | 4 | CID000071307 | |
| Drug | 2'CH3-MPTP | 1.86e-08 | 14 | 49 | 4 | CID000091767 | |
| Drug | tetrabenazine | 2.33e-08 | 40 | 49 | 5 | CID000006018 | |
| Drug | MFMD | 2.54e-08 | 15 | 49 | 4 | CID000122302 | |
| Drug | milacemide | 2.54e-08 | 15 | 49 | 4 | CID000053568 | |
| Drug | 5-hydroxytryptophol | 3.00e-08 | 42 | 49 | 5 | CID000009061 | |
| Drug | Ro 41-1049 | 3.38e-08 | 16 | 49 | 4 | CID000005086 | |
| Drug | nitecapone | 3.38e-08 | 16 | 49 | 4 | CID005464105 | |
| Drug | methoxytyramine | 3.38e-08 | 16 | 49 | 4 | CID000068384 | |
| Drug | 5-methyltryptamine | 4.41e-08 | 17 | 49 | 4 | CID000015760 | |
| Drug | N-desisopropylpropranolol | 4.41e-08 | 17 | 49 | 4 | CID000159899 | |
| Drug | NSC142627 | 4.41e-08 | 17 | 49 | 4 | CID000422254 | |
| Drug | alpha-methyltryptamine | 4.41e-08 | 17 | 49 | 4 | CID000009287 | |
| Drug | protriptyline | 5.67e-08 | 18 | 49 | 4 | CID000004976 | |
| Drug | 5-methoxyindole-3-acetic acid | 5.67e-08 | 18 | 49 | 4 | CID000018986 | |
| Drug | p-methoxyamphetamine | 7.16e-08 | 19 | 49 | 4 | CID000031721 | |
| Drug | 3-hydroxybenzyl | 7.16e-08 | 19 | 49 | 4 | CID000145655 | |
| Drug | norfenefrine | 7.16e-08 | 19 | 49 | 4 | CID000004538 | |
| Drug | 4-methylthioamphetamine | 7.16e-08 | 19 | 49 | 4 | CID000151900 | |
| Drug | m-tyramine | 7.16e-08 | 19 | 49 | 4 | CID000011492 | |
| Disease | response to vitamin | 6.91e-05 | 8 | 47 | 2 | GO_0033273 | |
| Disease | myopia (is_implicated_in) | 2.94e-04 | 16 | 47 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Antiglaucoma preparations and miotics use measurement | 7.88e-04 | 26 | 47 | 2 | EFO_0009944 | |
| Disease | Hyperglycemia, Postprandial | 1.05e-03 | 30 | 47 | 2 | C1855520 | |
| Disease | Hyperglycemia | 1.05e-03 | 30 | 47 | 2 | C0020456 | |
| Disease | joint hypermobility measurement | 1.27e-03 | 33 | 47 | 2 | EFO_0007905 | |
| Disease | Bladder Neoplasm | 1.45e-03 | 140 | 47 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.48e-03 | 141 | 47 | 3 | C0005684 | |
| Disease | heart rate response to exercise | 2.15e-03 | 43 | 47 | 2 | EFO_0009184 | |
| Disease | left ventricular diastolic function measurement | 3.37e-03 | 54 | 47 | 2 | EFO_0008204 | |
| Disease | pyroglutamine measurement | 3.88e-03 | 58 | 47 | 2 | EFO_0005408 | |
| Disease | diastolic blood pressure, systolic blood pressure | 4.15e-03 | 670 | 47 | 5 | EFO_0006335, EFO_0006336 | |
| Disease | tuberculosis | 4.95e-03 | 216 | 47 | 3 | MONDO_0018076 | |
| Disease | Nonorganic psychosis | 5.44e-03 | 69 | 47 | 2 | C0349204 | |
| Disease | response to ketamine | 5.44e-03 | 69 | 47 | 2 | EFO_0009748 | |
| Disease | diverticular disease | 6.32e-03 | 236 | 47 | 3 | EFO_0009959 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CREHFENHWKGRARW | 26 | Q96CB5 | |
| WPQGFSWSHRAVVHF | 776 | Q6L9W6 | |
| RASCPWYLPWHHHVA | 81 | P48546 | |
| HAREWIGPAFCQWFV | 196 | Q8N4T0 | |
| GIHAREWIAPAFCQW | 106 | Q8IVL8 | |
| AAGDHLVHHCPTWQW | 41 | Q9NT62 | |
| RCALALWHTWAPEHR | 666 | Q8IVL6 | |
| SVHRSWWREHGPGCV | 101 | Q8N8D7 | |
| DFRPKAGRHSWVWHE | 591 | P58215 | |
| FRPKTGRDSWVWHQC | 596 | Q96JB6 | |
| VHGYPVLAWHSARCW | 36 | P14324 | |
| PNRPRHTWEWHSCHQ | 436 | Q08397 | |
| FRPKNGRHAWIWHDC | 611 | Q9Y4K0 | |
| HWFSGPRCEVAVHWR | 3211 | Q02505 | |
| HWDGVHWNGRVHRCL | 226 | Q96HM7 | |
| KHWHAREGWECVFCG | 1561 | P24043 | |
| WRWHSCHSRVFIEGH | 101 | A8MTL0 | |
| HAREWVSPAFCQWFV | 176 | P15088 | |
| GWDTFCVKWSPHRAA | 2216 | Q99715 | |
| VLRHCFTEWQHWHGA | 401 | Q8NCU4 | |
| VWHVHGLWVCVDNFP | 201 | Q6Q6R5 | |
| CRDWRFVARHPAVWT | 576 | Q8TF61 | |
| FCRSCWHWRHSMEGL | 536 | Q9BZB8 | |
| RGWVRTHCCLEDAWH | 446 | Q8NFI3 | |
| RTHCPDWDSRESWGH | 6 | Q9HAZ1 | |
| WDCPARRWGHSECGH | 1006 | Q86VB7 | |
| HWIHWRCLFSAFRVE | 576 | Q8IX18 | |
| HAREWISPAFCQWFV | 176 | P15086 | |
| WFSGPRCEVTVHWRA | 1126 | Q9H195 | |
| INCPHISEAEWVRWH | 426 | Q8N8U3 | |
| HLRWHTGERPFVCNW | 316 | Q6BEB4 | |
| ATPKGWSCHWDRDHR | 596 | Q8N3X1 | |
| RVNPKSYGTWHHRCW | 101 | Q92696 | |
| ACGHLLSVWWRHRPQ | 251 | Q8NGU9 | |
| HLRWHTGERPFMCTW | 646 | P08047 | |
| WPVASFRHPQWTHRG | 201 | Q92502 | |
| TCPNTWLRAHAVWGR | 121 | Q495N2 | |
| HLRWHTGERPFVCNW | 376 | Q8IXZ3 | |
| HCRRHFPGWVALWLH | 61 | Q9BWE0 | |
| PFRHAWEAGCQAWDT | 336 | P0C7V6 | |
| AFRADGRWHHVCATW | 201 | Q7Z7M1 | |
| AVLSPGHRQWDCFWH | 281 | Q8TCY9 | |
| RWEARHGWTLPAHAS | 46 | Q8NFD4 | |
| RWLPVHVLREWQCGH | 536 | O14924 | |
| SSPCSWLRNHAHWGR | 126 | Q7Z2H8 | |
| HLRWHSGERPFVCNW | 641 | Q02447 | |
| HTWGFHTWLDVCRLP | 91 | A6NCN8 | |
| WRFWHDSEEVLGHFP | 71 | O95178 | |
| EYRRHWWRCNGPCQH | 161 | Q9H040 | |
| SRGWPLWHEHVPTAC | 556 | Q9HCJ5 | |
| PTVSCLRHWHMGDFW | 741 | Q9UI33 | |
| VFCWRHHTNPVGTEW | 421 | Q9NV66 |